Headache & Migraine
Conference Coverage
DIY nerve stimulation effective in episodic migraine
Participants in a new study applied neurostimulation for a continuous 2-hour period within 4 hours of a migraine attack.
Conference Coverage
Pandemic survey: Forty-six percent of pediatric headache patients got worse
But some fared better when they were stuck at home instead of at school.
News
FDA okays new oral CGRP antagonist for migraine prevention
With this approval, neurologists will be able to choose from four monoclonal antibodies and two gepants for the preventive treatment of migraine...
News
Assessing headache severity via migraine symptoms can help predict outcomes
“Our hope is that this work serves as foundational basis for better understanding the complexity of headache as a symptom-based condition.”
News
Atogepant reduces migraine days: ADVANCE trial results published
“Overall, this study showed us that atogepant was safe and surprisingly seems to be pretty effective regardless of the dose.”
News
Headache seen affecting some pregnancy outcomes
A new study links migraine – and also tension-type headache – to small-for-gestational-age babies.
Clinical Topics & News
Devices for the treatment of migraine
Literature Review
Trial finds that intranasal DHE is well tolerated and may reduce migraine symptoms
Most patients experienced symptom relief within 2 hours and reported that the medication was easy to use and preferable to their current therapy...
Literature Review
Virtual roller-coaster may explain the ups and downs of migraine
The prevalence of dizziness was 65% among patients with migraine who underwent a virtual roller-coaster ride, versus 30% among those without...
News
Occipital nerve stimulation offers relief for patients with intractable chronic cluster headache
The frequency of attacks may decrease with neuromodulation intervention, a new trial suggests.